This company listing is no longer active
Goodbody Health Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Goodbody Health.
Key information
-2.3%
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 14.8% |
Revenue growth rate | -81.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 24 Nov 2022 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 5 | -4 | -4 | -4 | 1 |
12/31/2022 | 11 | -4 | N/A | -5 | 1 |
9/30/2022 | 16 | -4 | -1 | -1 | N/A |
6/30/2022 | 20 | -2 | 0 | 1 | N/A |
3/31/2022 | 21 | -2 | 2 | 2 | N/A |
12/31/2021 | 17 | -2 | 2 | 2 | N/A |
9/30/2021 | 11 | -3 | -1 | -1 | N/A |
6/30/2021 | 6 | -4 | -2 | -2 | N/A |
3/31/2021 | 3 | -5 | -2 | -2 | N/A |
12/31/2020 | 2 | -5 | -3 | -2 | N/A |
9/30/2020 | 2 | -5 | -2 | -2 | N/A |
6/30/2020 | 2 | -5 | -3 | -3 | N/A |
3/31/2020 | 2 | -4 | N/A | N/A | N/A |
12/31/2019 | 1 | -4 | -3 | -3 | N/A |
9/30/2019 | 1 | -3 | -3 | -3 | N/A |
6/30/2019 | 1 | -3 | -3 | -3 | N/A |
3/31/2019 | 1 | -2 | N/A | N/A | N/A |
12/31/2018 | 0 | -2 | -2 | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GDBY is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GDBY is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GDBY is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: GDBY's revenue is expected to decline over the next 3 years (-81.4% per year).
High Growth Revenue: GDBY's revenue is forecast to decline over the next 3 years (-81.4% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GDBY's Return on Equity is forecast to be high in 3 years time